ClinicalTrials.Veeva

Menu

Vitamin D and HIV-Cardiovascular Disease in Children and Young Adults

University Hospitals (UH) logo

University Hospitals (UH)

Status

Completed

Conditions

Vitamin D Deficiency

Study type

Observational

Funder types

Other

Identifiers

NCT01410305
1R01HD070490-01

Details and patient eligibility

About

The relationship of Vitamin D levels in children and young adults to atherosclerosis.

Enrollment

290 patients

Sex

All

Ages

8 to 25 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria - Documentation of HIV Infection Between ages of 8 and 25

  • On stable ART for at least 12 weeks for the HIV+ patients
  • Cumulative duration of ART for at least 48 weeks for HIV + patients
  • Healthy child/young adult with age and race matched to HIV+ patient for the HIV- controls
  • Absence of HIV based on medical and medication history

Exclusion Criteria:

  • Taking > 800 IU of Vitamin D per day
  • Parathyroid or Calcium disorders
  • Acute illness and active inflammatory condition
  • Chronic illnesses that include malignancy, diabetes, CAD
  • Pregnancy and lactation
  • Creatinine Clearance <50 ml/min
  • Hgb < 9.0 g/dL
  • AST and ALT > 2.5 upper limits of normal

Trial design

290 participants in 2 patient groups

HIV+
Description:
HIV Positive children or young people between the ages of 8 and 25
HIV Negative
Description:
HIV Negative matched controls by age and race

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems